Table 1.
Variables of study between study groups
| Variables | Methylphenidate | Modafinil | Control | P-value | |
|---|---|---|---|---|---|
| Gender (m/f) | 10/9 | 7/13 | 4/4 | 0.51* | |
| Age | 36.94±15.87 | 36.57±10.63 | 34.25±14.51 | 0.89** | |
| Duration of disease (m) | 19.01±12.89 | 20.90±10.84 | 23.37±14.62 | 0.69** | |
| Frequent of seizure in months | 5.31±3.93 | 3.60±0.99 | 4.01±1.51 | 0.13** | |
| Number of used drugs | 3.70±1.04 | 3.35±1.08 | 2.62±0.74 | 0.04** | |
| ESS | Before | 16.78±3.39 | 16.30±3.18 | 13.87±3.09 | 0.10** |
| After | 14.15±4.40 | 12.45±3.50 | 13.87±3.44 | 0.37** | |
| P*** | <0.001 | <0.001 | 0.98 | ||
| TST (h) | Before | 12.84±2.67 | 12.85±2.58 | 9.25±1.66 | 0.003** |
| After | 10.10±1.79 | 9.80±2.62 | 9.37±1.76 | 0.72** | |
| P*** | <0.001 | <0.001 | 0.75 | ||
| Complications | No | 15 (78.9%) | 13 (65%) | 6 (75%) | 0.74** |
| Yes | 4 (21.1%) | 6 (30%) | 2 (25%) | ||
| Outcomes | Recovered | 5 (26.3%) | 11 (55%) | 2 (25%) | 0.07* |
| Not recovered | 9 (47.4%) | 8 (40%) | 6 (75%) | ||
| Partial recovery | 5 (26.3%) | 1 (5%) | 0 | ||
ESS: EPWORTH sleepiness scale, TST: Total sleep time.
*
Chi Square test;
**
Independent T tes;
***
One-way ANOVA.